Literature DB >> 8207248

Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma.

H U Simon1, P W Tsao, K A Siminovitch, G B Mills, K Blaser.   

Abstract

Platelet-activating factor (PAF) may play a role in the regulation of immune responsiveness and is a potent mediator in asthmatic inflammation. However, as yet, the mechanisms whereby PAF mediates its pleiomorphic effects on immune cells have not been elucidated. Because PAF is a potent chemotactic factor for eosinophils, the presence of receptors for PAF (PAFR) on lymphocytes may provide a mechanism for the concurrent recruitment of both eosinophils and T lymphocytes into the airways of asthmatic patients. To address this issue, we have examined freshly isolated PBMC and granulocytic cells as well as various T and B lymphocyte lines with regards to PAFR expression and PAF-induced changes in intracellular calcium concentration. Using two-color immunofluorescence techniques and highly purified cell populations, it was not possible to detect surface PAFR protein or functional PAFR on resting and in vivo or in vitro activated T and B cells derived from nonallergic individuals or patients with allergic asthma. In addition, we were unable to detect PAFR mRNA, protein, or functional response to PAF in human or murine T cell lines. In contrast, we found functional PAFR in most B lymphoblastoid cell lines. Within the PBMC population, CD14+ cells respond to PAF. These results suggest that PAF does not interact directly with lymphocytes and thus that previous observations suggestive of such an interaction likely reflect the effects of PAF on monocytes. PAF-induced increases in intracellular calcium concentration were also detected in neutrophils and eosinophils, but were lower in granulocytes relative to the levels detected in monocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207248

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation.

Authors:  Rommel Chacón-Salinas; Limo Chen; Alma D Chávez-Blanco; Alberto Y Limón-Flores; Ying Ma; Stephen E Ullrich
Journal:  J Leukoc Biol       Date:  2013-09-05       Impact factor: 4.962

2.  The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma.

Authors:  S Kruse; X Q Mao; A Heinzmann; S Blattmann; M H Roberts; S Braun; P S Gao; J Forster; J Kuehr; J M Hopkin; T Shirakawa; K A Deichmann
Journal:  Am J Hum Genet       Date:  2000-03-24       Impact factor: 11.025

3.  Regulation of platelet-activating factor receptor expression in human B cells and B cell lines.

Authors:  C M Nguer; D Treton; M Rola-Pleszczynski; Z Mishal; Y Thomas; P Galanaud; Y Richard
Journal:  Lipids       Date:  1996-10       Impact factor: 1.880

Review 4.  Microbial modulation of host immunity with the small molecule phosphorylcholine.

Authors:  Sarah E Clark; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

5.  Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.

Authors:  Salma Al-Darmaki; Kandi Knightshead; Yuichi Ishihara; Al Best; Harvey A Schenkein; John G Tew; Suzanne E Barbour
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

Review 6.  Platelet activating factor as a mediator and therapeutic approach in bronchial asthma.

Authors:  A Kasperska-Zajac; Z Brzoza; B Rogala
Journal:  Inflammation       Date:  2008-01-12       Impact factor: 4.092

7.  Platelet-activating factor induces Th17 cell differentiation.

Authors:  Anne-Marie Drolet; Maryse Thivierge; Sylvie Turcotte; Dominique Hanna; Bruno Maynard; Jana Stankovà; Marek Rola-Pleszczynski
Journal:  Mediators Inflamm       Date:  2011-10-13       Impact factor: 4.711

8.  Disruption of fas receptor signaling by nitric oxide in eosinophils.

Authors:  H Hebestreit; B Dibbert; I Balatti; D Braun; A Schapowal; K Blaser; H U Simon
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

9.  Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia.

Authors:  H U Simon; S Yousefi; C C Dommann-Scherrer; D R Zimmermann; S Bauer; J Barandun; K Blaser
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells.

Authors:  J O Utgaard; F L Jahnsen; A Bakka; P Brandtzaeg; G Haraldsen
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.